Accounts Receivable, Net

3 Months Ended

Mar. 31, 2014

Accounts Receivable, Net

Accounts Receivable, Net

E. Accounts Receivable, Net

Our net accounts receivable were $10.1 million and $6.8 million as of March 31, 2014 and December 31, 2013, respectively, and primarily represented amounts due from wholesalers and distributors to whom we sell Feraheme directly. Accounts receivable are recorded net of reserves for estimated chargeback obligations, prompt payment discounts and any allowance for doubtful accounts.

Customers which represented greater than 10% of our accounts receivable balances as of March 31, 2014 and December 31, 2013 were as follows:

	March 31, 2014		December 31, 2013
AmerisourceBergen Drug Corporation	52	%	49	%
McKesson Corporation	27	%	27	%
Cardinal Health, Inc.	15	%	16	%